CD44 and breast carcinoma: In this study, serum‐free suspension culture was used to identify CD44+CD24− breast cancer stem cells with high tumorigenic ability through enhanced expression of tumour stem cell markers, such as ALDH1A1, C‐Myc, OCT4, NANOG, KLF 4 and SOX2.